ArticleFrontiers in aging neuroscience2019
Dilated Saliency U-Net for White Matter Hyperintensities Segmentation Using Irregularity Age Map.
Article in Frontiers in aging neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 17 citations in OpenAlex.
- Deep optimization-guided hybrid neural network for accurate detection and segmentation of white matter hyperintensities in clinical MRI images.Scientific reports · 2026Article
- Cerebral small vessel disease lesion segmentation methods: A systematic review.Cerebral circulation - cognition and behavior · 2025Review
- White matter hyperintensities segmentation using an ensemble of neural networks.Human brain mapping · 2022Article
- Using Artificial Intelligence for Automatic Segmentation of CT Lung Images in Acute Respiratory Distress Syndrome.Frontiers in physiology · 2021Article
- Automatic spatial estimation of white matter hyperintensities evolution in brain MRI using disease evolution predictor deep neural networks.Medical image analysis · 2020Article
- Deep Learning and Neurology: A Systematic Review.Neurology and therapy · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
White matter hyperintensities (WMH) appear as regions of abnormally high signal intensity on T2-weighted magnetic resonance image (MRI) sequences. In particular, WMH have been noteworthy in age-related neuroscience for being a crucial biomarker for all types of dementia and brain aging processes. The automatic WMH segmentation is challenging because of their variable intensity range, size and shape. U-Net tackles this problem through the dense prediction and has shown competitive performances not only on WMH segmentation/detection but also on varied image segmentation tasks. However, its network architecture is high complex. In this study, we propose the use of Saliency U-Net and Irregularity map (IAM) to decrease the U-Net architectural complexity without performance loss. We trained Saliency U-Net using both: a T2-FLAIR MRI sequence and its correspondent IAM. Since IAM guides locating image intensity irregularities, in which WMH are possibly included, in the MRI slice, Saliency U-Net performs better than the original U-Net trained only using T2-FLAIR. The best performance was achieved with fewer parameters and shorter training time. Moreover, the application of dilated convolution enhanced Saliency U-Net by recognizing the shape of large WMH more accurately through multi-context learning. This network named Dilated Saliency U-Net improved Dice coefficient score to 0.5588 which was the best score among our experimental models, and recorded a relatively good sensitivity of 0.4747 with the shortest training time and the least number of parameters. In conclusion, based on our experimental results, incorporating IAM through Dilated Saliency U-Net resulted an appropriate approach for WMH segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.